A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques.
18 hours ago
0
37
Trinity researchers have examined the effectiveness of a new blood test which could change the way Alzheimer's disease is identified. The blood test (plasma p-tau217) detects the presence of amyloid plaques that build up ...
Aug 23, 2024
0
117
People with Down syndrome are likely to develop Alzheimer's disease at a young age, with autopsy studies showing that by age 40 years, the brains of individuals with Down syndrome have amyloid plaques. Yet people with Down ...
Aug 19, 2024
0
0
